Advanced Human Imaging Limited Sponsored ADR AHI
- Market cap
- $13.2M
- P/E
- 0.0×
Follow AHI
Target Price Range
Analyst price targets
Free account| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | 12.16 | 1.40 | 0.64 |
Analyst estimates 2024–2026 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | 31.08 | 20.92 | 15.52 |
High Price
|
|||
| — | — | — | — | — | — | — | 19 | 19 | 32 |
Employees
|
|||
| — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | 1 | 0 | 1 | 1 | 0 | 2 |
Revenue
|
|||
| — | — | — | 0.00% | 88.39% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Gross Margin
|
|||
| — | — | — | (2) | (11) | (4) | (6) | (15) | (15) | (9) |
EBT
|
|||
| — | — | — | 0.00% | (921.85%) | (122,443.48%) | (908.68%) | (1,234.75%) | (4,731.42%) | (459.69%) |
EBT Margin
|
|||
| — | — | — | 0 | (10) | (3) | (5) | (14) | (15) | (9) |
Net Income
|
|||
| — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation
|
|||
| — | — | — | 0.00 | 0.10 | 0.00 | 0.18 | 0.27 | 0.06 | 0.28 |
Revenue/Sh
|
|||
| — | — | — | (0.02) | (0.13) | (0.03) | (1.44) | (3.14) | (2.66) | (1.24) |
Earnings/Sh
|
|||
| — | — | — | (0.11) | (0.08) | (0.64) | (0.72) | (0.92) | (1.30) | (0.75) |
Cash Flow/Sh
|
|||
| — | — | — | 0.00 | 0.00 | 0.00 | (0.02) | (0.01) | (0.01) | (0.01) |
Capex/Sh
|
|||
| — | — | — | (0.11) | (0.08) | (0.64) | (0.74) | (0.92) | (1.32) | (0.76) |
Free CF/Sh
|
|||
| — | — | — | 0.14 | 0.04 | 0.11 | 0.12 | 0.44 | 1.13 | 0.21 |
Book Value/Sh
|
|||
| — | — | — | 13 | 12 | 4 | 4 | 4 | 5 | 7 |
Shares
|
|||
| — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PE Ratio
|
|||
| — | — | — | — | 519.26 | 519.26 | 519.26 | 519.26 | 66.00 | 112.47 |
PS Ratio
|
|||
| — | — | — | — | 145.13 | 145.13 | 145.13 | 145.13 | 6.34 | 47.60 |
PB Ratio
|
|||
| — | — | — | — | 519.37 | 519.37 | 519.37 | 519.37 | 60.12 | 112.04 |
EV/Sales
|
|||
| — | — | — | — | (32.09) | (32.09) | (32.09) | (32.09) | (2.41) | (3.66) |
EV/FCF
|
|||
| — | — | — | (1) | (1) | (2) | (3) | (4) | (7) | (5) |
Op' Cash Flow
|
|||
| — | — | — | (1) | 0 | 0 | 0 | 0 | 0 | 0 |
Capex
|
|||
| — | — | — | (1) | (1) | (2) | (3) | (4) | (7) | (5) |
FCF
|
|||
| — | — | — | 1 | 0 | (1) | (1) | 1 | 4 | (2) |
Working Cap'
|
|||
| — | — | — | — | 0 | 1 | 1 | 2 | 1 | 1 |
Total Debt
|
|||
| — | — | — | (1) | 0 | 1 | 1 | 0 | (4) | 0 |
Net Debt
|
|||
| — | — | — | 2 | 1 | 0 | 0 | 2 | 6 | 1 |
Sh' Equity
|
|||
| — | — | — | (90.94%) | (1,384.20%) | (183.02%) | (225.12%) | (335.76%) | (221.40%) | (125.76%) |
ROA
|
|||
| — | — | — | 0.00% | 0.00% | 0.00% | (318.73%) | (449.56%) | (358.47%) | (474.08%) |
ROIC
|
|||
| — | — | — | (138.90%) | (850.28%) | (677.61%) | (1,275.35%) | (1,152.26%) | (355.91%) | (228.08%) |
ROE
|
|||
Advanced Human Imaging Limited Sponsored ADR peers in Software Application
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| BIYA Baiya International Group Inc. | $13.2M | — | Compare |
| YXT YXT.COM Group Holding Limited - Unsponsored ADR | $13.0M | — | Compare |
| RCT RedCloud Holdings plc | $13.8M | — | Compare |
| SAGT SAGTEC GLOBAL LIMITED | $14.4M | — | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| RPGL Republic Power Group Limited | $14.8M | — | Compare |
| YMT Yimutian Inc. - Sponsored ADR | $11.6M | — | Compare |
| SMSI Smith Micro Software, Inc. | $15.1M | 0.0× | Compare |
| CYN Cyngn Inc. | $11.3M | 0.0× | Compare |
Advanced Human Imaging Limited Sponsored ADR (AHI) key facts
- Advanced Human Imaging Limited Sponsored ADR (AHI) is a Software Application company in the Technology sector, traded in the US as an ADR.
- Advanced Human Imaging Limited Sponsored ADR’s revenue for fiscal 2023 (year ended June 2023) was AUD 1.9 million, up 484.3% from fiscal 2022.
- As of August 14, 2025, AHI traded at $1.50, a market capitalization of $13.2 million.
- Return on equity was −228.1% and debt-to-equity -1.14.
Advanced Human Imaging Limited Sponsored ADR (AHI) Latest News
22 Jan
Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on January 24th & 25th at 9:00 A.M. ET. The conference may moderately influence AHI's future performance and market sentiment.
18 Jan
AHI CEO to present at Microcap Conference in Atlantic City, discussing digital health solutions and commercial partnerships. Significant impact expected on AHI's future with updates on technology, partnerships, and commercial milestones.
3 Nov
AHI signs binding term sheet with OneClinic for Vietnam to integrate biometric health assessment capabilities into OneClinic's digital health record system. The partnership with OneClinic and the potential launch of the integrated solution in Vietnam could significantly impact AHI's future market performance.
19 Oct
Dr. Walid Abbas Zaher honored as a top healthcare leader by Forbes Middle East for his contributions to healthcare and clinical research. The collaboration between AHI and IntelliGen led by Dr. Zaher is expected to have a significant impact on healthcare solutions and standards in the Middle East.
9 Oct
AHI partner Bearn LLC collaborates with OnCore Innovations Inc. to integrate biometrics into golf experience for health benefits. The collaboration between Bearn and OnCore Innovations is expected to have a significant impact on AHI's future by integrating biometrics into the golfing experience for health benefits.
27 Sep
AHI partner Bearn LLC signs commercial partnership with AIG Insurance to streamline underwriting solutions and reward users for better health outcomes. The partnership with AIG has the potential to significantly impact AHI's future market performance and strategic positioning.
20 Sep
AHI signs LOI with Unisure and SCOR to develop digital underwriting solution for insurance industry. Partnership with major players in insurance industry expected to significantly impact AHI's future and market performance.
13 Sep
AHI selected as finalist for Singapore Ministry of Health project. AHI's participation in the project could significantly impact its future trajectory and market performance.
12 Sep
Advanced Health Intelligence Ltd secures $1.5M funding via convertible loan facility, with potential to increase to $5M. Terms include 24-month maturity, 10% interest, and conversion to shares at A$0.30/share. The funding secured through the convertible loan facility has the potential to significantly impact AHI's future financial performance and strategic direction.
8 Sep
AHI collaborates with Bin Farhood Group to deploy technology in MENA region. The collaboration is expected to have a significant impact on AHI's future growth and market performance.
17 Aug
Advanced Health Intelligence Ltd obtains 43.5% reimbursement for overseas R&D under Australia's R&DTI scheme, enabling further global innovation and talent acquisition. Significant impact expected on AHI's future growth, innovation, and global competitiveness.
14 Aug
Advanced Health Intelligence Ltd signs collaboration agreement with IntelliGen FZ-LLC. The collaboration agreement with IntelliGen FZ-LLC is a significant move that could alter AHI's trajectory and market sentiment.
2 Aug
AHI signs exclusive license deal with Changlin Network Technology Ltd to bring digital healthcare solutions to China. The exclusive license deal with Changlin has the potential to significantly impact AHI's future market performance and strategic positioning.
1 Aug
AHI reported strong financial progress and partnerships in Q2 2023, including FDA submissions, NASDAQ compliance, debt reduction, and $5m placement. Expanded capabilities showcased at BCG summit. New biometric health assessment offering. Partner-friendly delivery methods introduced. Cost consolidation achieved. Funding proposals received post-quarter. Significant impact likely on future and performance with transformative initiatives, partnerships, and financial progress.
5 Jul
Advanced Health Intelligence Ltd provides shareholder update on smartphone-based biometric health assessment and collaboration with Stellenbosch University. FDA submissions underway for BodyScan categorization. The collaboration with Stellenbosch University and FDA submissions for BodyScan categorization are significant developments that could have a major impact on AHI's future and market performance.
29 Jun
Advanced Health Intelligence Ltd announces implementation of ADS ratio change. The ratio change is expected to have a significant impact on the company's future performance and market dynamics.
1 May
AHI completes integration of acquired platforms, releases new biometric health assessment software, receives funding, updates on commercial partners, and reports highest quarterly revenue. Significant impact likely on future and performance due to strategic moves, new product offerings, revenue growth, and partnerships.